DOPAMINE-ACETYLCHOLINE BALANCE IN NUCLEUS ACCUMBENS AND CORPUS STRIATUM AND ITS EFFECT ON HYPOTHALAMIC SELF-STIMULATION

被引:26
作者
STEPHENS, DN [1 ]
HERBERG, LJ [1 ]
机构
[1] INST NEUROL, EXPTL PSYCHOL LAB, QUEEN SQ, LONDON WC1N 3BG, ENGLAND
关键词
Anticholinergics; Benztropine; Corpus striatum; Extinction; Neuroleptics; Nucleus accumbens; Scopolamine; Self-stimulation; Spiroperidol;
D O I
10.1016/0014-2999(79)90062-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Three experiments investigated the suppression of hypothalamic self-stimulation in rats by neuroleptics and its restoration by centrally acting anticholinergic agents. Scopolamine (0.1-1.0 mg/kg i.p) and benztropine (1.0-10.0 mg/kg i.p.) each enhanced self-stimulation when administered alone, and partially restored performance suppressed by spiroperidol (0.05-0.15 mg/kg i.p.). Benztropine strongly inhibits transmitter reuptake at DA synapses but scopolamine does not, thus inhibition of DA reuptake cannot fully account for the stimulant or antineuroleptic action of anticholinergic drugs. Neuroleptic and anticholinergic effects on self-stimulation rate were mutually subtractive, and statistical evidence of interaction was not obtained. Scopolamine was shown also to restore performance extinguished by discontinuation of the stimulating current. Smaller doses of scopolamine (50 nmol; 19 μg) injected directly into the nucleus accumbens septi partially restored responding suppressed by spiroperidol, though similar doses of scopolamine injected bilaterally into the caudate-putamen were ineffective. These findings suggest that hypothalamic self-stimulation may be influenced by ACh- and DA-containing systems which exert independent effects on a third system controlling performance. These effects appear to reflect the level of arousal or motivation rather than the reinforcement process itself. © 1979.
引用
收藏
页码:331 / 339
页数:9
相关论文
共 36 条
[1]  
BARBEAU A, 1962, CAN MED ASSOC J, V87, P802
[2]   METHYLPHENIDATE-LIKE EFFECTS OF NEW ANTIDEPRESSANT DRUG NOMIFENSINE (HOE 984) [J].
BRAESTRUP, C ;
SCHEELKRUGER, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1976, 38 (02) :305-312
[3]   CHOLINERGIC MECHANISMS IN THE CONTROL OF BEHAVIOR BY THE BRAIN [J].
CARLTON, PL .
PSYCHOLOGICAL REVIEW, 1963, 70 (01) :19-39
[4]   DECREASE IN RAT STRIATAL ACETYLCHOLINE LEVELS BY SOME DIRECT-ACTING AND INDIRECT-ACTING DOPAMINERGIC ANTAGONISTS [J].
CONSOLO, S ;
LADINSKY, H ;
BIANCHI, S .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1975, 33 (02) :345-351
[5]   APPARENT LACK OF A DOPAMINERGIC-CHOLINERGIC LINK IN RAT NUCLEUS ACCUMBENS SEPTI-TUBERCULUM OLFACTORIUM [J].
CONSOLO, S ;
LADINSKY, H ;
BIANCHI, S ;
GHEZZI, D .
BRAIN RESEARCH, 1977, 135 (02) :255-263
[6]   ANTIPARKINSONIAN DRUGS - INHIBITION OF DOPAMINE UPTAKE IN CORPUS STRIATUM AS A POSSIBLE MECHANISM OF ACTION [J].
COYLE, JT ;
SNYDER, SH .
SCIENCE, 1969, 166 (3907) :899-+
[7]   ENHANCEMENT BY COCAINE OF INTRA-CRANIAL SELF-STIMULATION IN RAT [J].
CROW, TJ .
LIFE SCIENCE PART 1 PHYSIOLOGY & PHARMACOLOGY, 1970, 9 (07) :375-&
[9]  
De Groot J., 1959, RAT FOREBRAIN STEREO
[10]   CHOLINERGIC-ANTICHOLINERGIC ANTAGONISM IN PARKINSONISM [J].
DUVOISIN, RC .
ARCHIVES OF NEUROLOGY, 1967, 17 (02) :124-+